What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review.

Authors:
Address: Department of Physiotherapy, Alfred Hospital, Melbourne, Australia.
Journal:


Publication:

abstract

pulmonary rehabilitation is an essential component of care for people with chronic obstructive pulmonary disease (COPD) and is supported by strong scientific evidence. Despite this, many people with COPD do not complete their program or choose not to attend at all. The aim of this study was to determine the factors associated with uptake and completion of pulmonary rehabilitation for people with COPD. Seven electronic databases were searched for qualitative or quantitative studies that documented factors associated with uptake and completion of pulmonary rehabilitation in people with COPD. Two reviewers independently extracted data, which was synthesized to provide overall themes. Travel and transport were consistently identified as barriers to both uptake and completion. A lack of perceived benefit of pulmonary rehabilitation also influenced both uptake and completion. The only demographic features that consistently predicted non-completion were being a current smoker (pooled odds ratio 0.17, 95% confidence interval 0.10 to 0.32) and depression. The limited data available regarding barriers to uptake indicated that disruption to usual routine, influence of the referring doctor and program timing were important. In conclusion poor access to transport and lack of perceived benefit affect uptake of pulmonary rehabilitation. Current smokers and patients who are depressed are at increased risk of non-completion. Enhancing attendance in pulmonary rehabilitation will require more attention to transportation, support for those at risk of non-completion and greater involvement of patients in informed decisions about their care.



Related Articles
Lack of perceived benefit and inadequate transport influence uptake and completion of pulmonary rehabilitation in people with chronic obstructive pulmonary disease: a qualitative study.
J Physiother. 2011
Lack of perceived benefit and inadequate transport influence uptake and completion of pulmonary rehabilitation in people with chronic obstructive pulmonary disease: a qualitative study.
Keating A, Lee AL, Holland AE. J Physiother. 2011; 57(3):183-90.
Adherence to pulmonary rehabilitation: A qualitative study.
Respir Med. 2006
Adherence to pulmonary rehabilitation: A qualitative study.
Arnold E, Bruton A, Ellis-Hill C. Respir Med. 2006 Oct; 100(10):1716-23. Epub 2006 Mar 22.
Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables.
Respir Med. 2009
Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables.
Fischer MJ, Scharloo M, Abbink JJ, van 't Hul AJ, van Ranst D, Rudolphus A, Weinman J, Rabe KF, Kaptein AA. Respir Med. 2009 Oct; 103(10):1564-71. Epub 2009 May 29.
Review Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease?
Curr Opin Pulm Med. 2009
Review Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease?
Coventry PA. Curr Opin Pulm Med. 2009 Mar; 15(2):143-9.
Review Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups.
Health Technol Assess. 2004
Review Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups.
Beswick AD, Rees K, Griebsch I, Taylor FC, Burke M, West RR, Victory J, Brown J, Taylor RS, Ebrahim S. Health Technol Assess. 2004 Oct; 8(41):iii-iv, ix-x, 1-152.
Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population.
Int J Chron Obstruct Pulmon Di...
Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population.
Dalal AA, Shah M, D'Souza AO, Chaudhari S, Crater G. Int J Chron Obstruct Pulmon Dis. 2012; 7:11-9. Epub 2012 Jan 18.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.